The Critical Path Institute (C-Path) is a catalyst in the development of new approaches to advance medical innovation and regulatory science, with the ultimate goal of getting life-changing therapies to patients sooner. We achieve this by leading teams that share data, knowledge and expertise, resulting in sound, consensus-based science.
As an independent 501(c)(3) nonprofit, C-Path relies upon support from a diverse array of funders who share a common belief: the regulatory path therapies travel to reach patients should be improved and accelerated.
Thanks to initial funding in 2005 from individuals, municipalities and organizations in Southern Arizona, C-Path’s support has grown to include organizations like the U.S. Food and Drug Administration, the Bill and Melinda Gates Foundation and the Flinn Foundation. C-Path pioneered the consortia-driven approach to advance regulatory science and has developed a global reputation as a trusted organization that brings together a wide variety of collaborators from industry, government and academia. Its track record of creating successful public and private partnerships enables C-Path and its collaborators to continually develop and achieve regulatory pathway innovations that help more patients in more disease areas.
Your contribution will break down barriers and help lifesaving therapies reach patients more efficiently and effectively. If you have questions about how your donation will make an impact, please email [email protected] or download our most recent annual report.
Thank you very much for your interest and support!
Anyone can make a secure donation directly to Critical Path Institute by clicking on Donate. In addition, as a participant in the AmazonSmile program, you can designate
C-Path as the charitable organization you want to receive 0.5% of the price of your eligible AmazonSmile purchases.